Feature

Neuropathy drives hypoglycemia cluelessness in T1D


 

Limitations

  • The study used a cross-sectional design, which is not suited to making causal inferences.
  • The authors characterized DPN as either present or absent. They did not evaluate or analyze the severity of peripheral neuropathy.
  • The authors evaluated diabetic cardiac autonomic neuropathy (DCAN) by a person’s coefficient of variation of R-R intervals, and definitive diagnosis of DCAN required at least two positive results on a cardiac autonomic test. More vigorous evaluation using a more definitive assessment of DCAN is needed to relate DCAN and IAH status.

Disclosures

  • The study received no commercial funding.
  • The authors have disclosed no relevant financial relationships.

This is a summary of a preprint research study, “Protective and risk factors of impaired awareness of hypoglycemia in patients with type 1 diabetes: a cross- sectional analysis of baseline data from the PR-IAH study,” written by researchers at several hospitals in Japan, all affiliated with the National Hospital Organization, on Research Square. The study has not yet been peer reviewed. The full text of the study can be found on researchsquare.com.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Cutting dietary simple sugars may relieve GERD symptoms
MDedge Internal Medicine
Bevacizumab first matches aflibercept for diabetic macular edema
MDedge Internal Medicine
Moderate drinking shows more benefit for older vs. younger adults
MDedge Internal Medicine
Number of steps per day needed to prevent death in diabetes
MDedge Internal Medicine
Statins linked to lower diabetes risk after acute pancreatitis
MDedge Internal Medicine
New update focuses on NAFLD in lean people
MDedge Internal Medicine
Metabolic syndrome raises dementia risk in under-60s
MDedge Internal Medicine
Medicare advantage tied to less use of pricey diabetes drugs
MDedge Internal Medicine
Remnant cholesterol captures residual CV risk in patients with T2D
MDedge Internal Medicine
‘Staggering’ CVD rise projected in U.S., especially in minorities
MDedge Internal Medicine